Keywords: hmr, launches, tavanic, uk, hoechst, marion, roussel
HMR Launches Tavanic In UK
Article | 02 April 1998
Hoechst Marion Roussel has launched the once-daily quinoloneantibiotic Tavanic (levofloxacin) in the UK. Levofloxacin has activity against Streptococcus pneumoniae, including ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
